期刊论文详细信息
Journal of Experimental & Clinical Cancer Research 卷:38
A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer
Gabriele Babini1  Angiola Desiderio2  Maria Elena Villani2  Mariateresa Mancuso3  Anna Saran3  Carmela Marino3  Alessandra Battaglia4  Marco Petrillo4  Giovanni Scambia4  Gabriella Ferrandina4  Andrea Scaloni5  Chiara D’Ambrosio5  Alessandra Ciucci6  Marianna Buttarelli6  Daniela Gallo6  Flavia Filippetti6  Giuseppina Raspaglio6 
[1] Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli, IRCCS;
[2] Division of Biotechnologies and Agroindustry, Department for Sustainability, National Agency for Energy, New Technologies and Sustainable Economic Development (ENEA);
[3] Division of Health Protection Technology, Department for Sustainability, National Agency for Energy, New Technologies and Sustainable Economic Development (ENEA);
[4] Istituto di Clinica Ostetrica e Ginecologica, Università Cattolica del Sacro Cuore;
[5] Proteomics and Mass Spectrometry Laboratory, ISPAAM-National Research Council;
[6] Unit of Translational Medicine for Woman and Child Health, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli, IRCCS;
关键词: Cervix;    LACC;    Molecular biomarkers;    Personalized medicine;    Proteomics;   
DOI  :  10.1186/s13046-019-1268-y
来源: DOAJ
【 摘 要 】

Abstract Background A better understanding of locally advanced cervical cancer (LACC) is mandatory for further improving the rates of disease control, since a significant proportion of patients still fail to respond or undergo relapse after concurrent chemoradiation treatment (CRT), and survival for these patients has generally remained poor. Methods To identify specific markers of CRT response, we compared pretreatment biopsies from LACC patients with pathological complete response (sensitive) with those from patients showing macroscopic residual tumor (resistant) after neoadjuvant CRT, using a proteomic approach integrated with gene expression profiling. The study of the underpinning mechanisms of chemoradiation response was carried out through in vitro models of cervical cancer. Results We identified annexin A2 (ANXA2), N-myc downstream regulated gene 1 (NDRG1) and signal transducer and activator of transcription 1 (STAT1) as biomarkers of LACC patients’ responsiveness to CRT. The dataset collected through qPCR on these genes was used as training dataset to implement a Random Forest algorithm able to predict the response of new patients to this treatment. Mechanistic investigations demonstrated the key role of the identified genes in the balance between death and survival of tumor cells. Conclusions Our results define a predictive gene signature that can help in cervical cancer patient stratification, thus providing a useful tool towards more personalized treatment modalities.

【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:0次